Osaka Soda Co (4046) Q4 2025 earnings summary

Executive summary

• Achieved sales and profit growth in FY2024, with net income exceeding ¥10 billion, the second highest on record after FY2022.

• Net sales rose 2.0% year-over-year to ¥96,434 million, with operating profit up 26.2% to ¥13,246 million and profit attributable to owners of parent up 35.0% to ¥10,332 million.

• Business performance improved year-over-year due to resolution of production issues and growth in the Healthcare segment, though initial plans were not fully met due to delayed market recovery.

• The group advanced its medium-term plan, focusing on strengthening core businesses, new product creation, and sustainability management.

• Recovery in the Japanese economy was offset by global uncertainties, including high raw material costs and geopolitical risks.

Financial highlights

• FY2024 net sales: ¥96.4 billion (up ¥1.9 billion YoY); operating income: ¥13.2 billion (up ¥2.8 billion YoY); net income: ¥10.3 billion (up ¥2.7 billion YoY).

• Overseas sales increased to ¥36.2 billion, representing 37.5% of total sales.

• EPS rose to ¥81.54 (assuming stock split at period start).

• Ordinary profit increased 17.9% year-over-year to ¥14,154 million.

• Cash and cash equivalents at year-end were ¥43,314 million, up ¥4,881 million from the prior year.

Outlook and guidance

• FY2025 targets record-high profits: net sales ¥102 billion, operating income ¥17 billion, net income ¥12.3 billion, EPS ¥97.70.

• Each profit metric is projected to reach record highs.

• Profit improvement expected from resolved production issues and strong Healthcare performance; risks include Chinese economic concerns and global downturn.

• Strategic focus remains on operational reforms, product innovation, and sustainability.